Research ArticleNEUROPHARMACOLOGY
Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons
Simon Akerman, Philip R. Holland and Peter J. Goadsby
Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 64-71; DOI: https://doi.org/10.1124/jpet.106.106971